Washington, D.C. – Congressman Patrick J. Kennedy (D-RI) announced today that he will introduce legislation designed to unite and expand federal neurotechnology research and development efforts under a National Neurotechnology Initiative (NNTI). Using targeted funding increases, totaling less than 4 percent of the total brain and central nervous system research budget, the National Neurotechnology Initiative Act will ease bottlenecks, increase coordination, and result in critical treatments reaching patients faster.

“The passage of mental health parity legislation in the House was an important step towards bringing greater attention to brain-related illness. It is important that we continue taking steps to better understand and ultimately develop treatments for all the various illnesses of the human brain,” says Kennedy. “The brain is the most important component of the human body, and with so many Americans suffering from brain-related illnesses, it is crucial for us as a society to maximize our efforts and continue learning about the many facets of the brain, leading to a healthier life for all Americans,” adds Kennedy.

"One out of every three Americans is living with a brain or nervous system disorder," said Zack Lynch, Executive Director of the Neurotechnology Industry Organization. "The need is clear and the neuroscience community knows what to do. Now we need a coordinated Federal effort to help accelerate research and transform discoveries into actual treatments. We need more champions like Representative Kennedy whose passion and commitment is helping to finally give the brain a voice,” adds Lynch.

Key provisions of the legislation are outlined below (FY09 Authorization levels are in parentheses):

Coordinates Interagency Neurotechnology Research and Development

*Creates a National Neurotechnology Initiative that supports and coordinates NIH and interagency neurotechnology research and development, including partnerships with small businesses and coordination with the FDA.
Establishes a National Neurotechnology

*Coordinating Office within the Department of Health and Human Services to implement the NNTI, help agencies such as the VA, Defense Department, and HHS plan joint and complementary research strategies, and serve as the unified voice of federal neurotechnology efforts ($5 million).

*Creates an advisory panel of experts from industry, academic institutions, and non-profit organizations to inform the NNTI on issues including R&D priorities, technology transfer, commercial applications, and ethical, legal, and social issues.

Supports Inter-Institute NIH Neurotechnology Research and Development

*Authorizes the ongoing NIH Blueprint for Neuroscience Research, a collaboration between the 16 NIH Institutes involved in brain and nervous system research.

*Provides a steady source of sufficient funding for the Blueprint ($80 million).

*Accelerates NIH Partnerships with Innovative Neurotechnology Small Businesses

Increases NIH funding for SBIR and STTR programs, with an emphasis on translational neurotechnologies ($75 million).

Increases Neuroscience Staff and Training at the Food and Drug Administration

*Provides funding for the FDA to increase neuroscience-related staff, provide funds for training and to develop workshops to improve the timelines and safety of the neurotech review process ($30 million).

*Examines of Ethical, Legal, and Social Issues

*Provides for a research center to conduct studies on the ethical, legal and social implications of neurotechnology, addressing issues such as its appropriate use in the criminal justice system, or enhancement of soldier and civilian mental capabilities ($10 million).